rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Stuart Cobb

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, Neurogene.

In numbers

Trades disclosed
13
Buys
0
Sells
2
Bought
$0
Sold
$386K
Companies
1
Companies where not an officer
0
First trade
13 Mar 2024
Last trade
13 Mar 2026
Last filed
17 Mar 2026

Companies traded

Where they are an officer
NGNE NeurogeneOfficer · Biotechnology · last 13 Mar 20260 buys · 2 sells

Activity over time

1 May 2025 – 1 Oct 2026
10May 25Sep 25Feb 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
13 Mar 2026filed 17 Mar 2026NGNE NeurogeneBiotechnologySEC FORM 4 Sold$81K3,991 at $20.41filing
13 Mar 2026filed 17 Mar 2026NGNE NeurogeneBiotechnologySEC FORM 4 Sold$57K2,658 at $21.34filing
13 Mar 2026filed 17 Mar 2026NGNE NeurogeneBiotechnologySEC FORM 4 Sold$3,268148 at $22.08filing
13 Mar 2026filed 17 Mar 2026NGNE NeurogeneBiotechnologySEC FORM 4 Sold$81K3,991 at $20.41filing
13 Mar 2026filed 17 Mar 2026NGNE NeurogeneBiotechnologySEC FORM 4 Sold$57K2,658 at $21.34filing
13 Mar 2026filed 17 Mar 2026NGNE NeurogeneBiotechnologySEC FORM 4 Sold$3,268148 at $22.08filing
20 Feb 2026filed 24 Feb 2026NGNE NeurogeneBiotechnologySEC FORM 4 Code A—16,500 at $0.00filing
20 Feb 2026filed 24 Feb 2026NGNE NeurogeneBiotechnologySEC FORM 4 Code A—16,500 at $0.00filing
14 May 2025filed 15 May 2025NGNE NeurogeneBiotechnologySEC FORM 4 Sold$103K6,797 at $15.15filing
26 Mar 2025filed 28 Mar 2025NGNE Neurogeneoption or derivative · BiotechnologySEC FORM 4 Code A—42,900 at $0.00filing
26 Mar 2025filed 28 Mar 2025NGNE NeurogeneBiotechnologySEC FORM 4 Code A—7,200 at $0.00filing
13 Mar 2024filed 14 Mar 2024NGNE Neurogeneoption or derivative · BiotechnologySEC FORM 4 Code A—34,450 at $0.00filing
13 Mar 2024filed 14 Mar 2024NGNE NeurogeneBiotechnologySEC FORM 4 Code A—20,391 at $0.00filing

News

Stuart Cobbeaccountingtoday.com · 15 Oct 2026

1 headline in the last 90 days name Stuart Cobb; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Rachel McMinnChief Executive Officer · Chief Executive Officer at Neurogene, filing Form 4 there in the last year
Christine Mikail CvijicPresident and CFO · President and CFO at Neurogene, filing Form 4 there in the last year
Keith WoodsChief Operating Officer · Director at Neurogene, filing Form 4 there in the last year
Christina ShaferChief Commercial Officer · Chief Commercial Officer at Neurogene, filing Form 4 there in the last year
Julie JordanChief Medical Officer · Chief Medical Officer at Neurogene, filing Form 4 there in the last year